PGHH Q1 FY27 Results Analysis: PAT Plunges 34%, Margin Collapses 933 bps
Procter & Gamble Hygiene and Health Care Ltd reported Q1 FY27 numbers with revenue of Rs. 891.46 Cr (-4.86% YoY) and PAT growth of -34.25% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 29, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 891.46 Cr (-4.86% YoY) |
| PAT (Q1) | Rs. 126.27 Cr (-34.25% YoY) |
| EBITDA margin | 19.08% (-933 bps YoY) |
| EPS (Q1) | Rs. 38.90 (-34.26% YoY) |
| Market cap | Rs. 27,877.39 Cr |
| CMP | Rs. 8,593.00 |
Quarter Snapshot
PGHH reported a weak Q1 with revenue declining 4.86% YoY and EBITDA margin collapsing 933 bps to 19.08% due to severe commodity inflation. PAT fell 34% YoY, contradicting management's qualitative guidance of double-digit earnings growth. No near-term catalysts are evident, and the competitive position appears weakened.
Key Investment Insights
Key Positives
- Other expenses as a % of revenue remained stable at 22.82% vs 22.69% a year ago
- Effective tax rate improved to 25.56% from 27.44% a year ago
- No exceptional items or one-time charges in the quarter
Risk Factors
- Revenue declined 4.86% YoY to Rs.891.46 Cr, a weak start to FY27
- EBITDA margin collapsed 933 bps YoY to 19.08% due to surging material costs
- PAT declined 34.25% YoY to Rs.126.27 Cr, the steepest drop in recent quarters
- Gross material cost rose 12.7% YoY despite revenue decline, driven by commodity inflation
- Employee costs rose 12.4% YoY, adding to cost pressure
- Management's stated goal of 'sustaining double-digit earnings growth' appears off-track with a 34% PAT decline
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.